1.Hypofractionated High-Dose Intensity-Modulated Radiotherapy (60 Gy at 2.5 Gy per Fraction) for Recurrent Renal Cell Carcinoma: A Case Report.
Jaeho CHO ; Gwi Eon KIM ; Koon Ho RHA ; Joong Bae AHN ; Chang Geol LEE ; Chang Ok SUH ; Jinsil SEONG ; Ki Chang KEUM ; Song Ie KIM ; Yoon Hee LEE
Journal of Korean Medical Science 2008;23(4):740-743
A patient with renal cell carcinoma (RCC) developed synchronous bone metastasis with metachronous relapses to the bone and renal fossa. The primary lesion was initially removed surgically, and the metastatic bone lesions and locally recurrent tumours were treated by a high-fractional dose and high-total-dose intensitymodulated radiotherapy (IMRT, 60 Gy at 2.5 Gy per fraction) without significant side effects. All the grossly relapsed tumors underwent complete remission (CR) within a short time after IMRT. To date, CR has been maintained for more than two years. This case study reports the successful treatment of radioresistant RCC using a new scheme that involves a fractionation regimen with a high precision radiotherapy.
Carcinoma, Renal Cell/pathology/*radiotherapy
;
Dose Fractionation
;
Female
;
Humans
;
Kidney Neoplasms/pathology/*radiotherapy
;
Middle Aged
;
Neoplasm Recurrence, Local/pathology/*radiotherapy
;
Radiotherapy, Intensity-Modulated
2.Renal Bellini's collecting duct carcinoma: report of a case.
Wei WANG ; Guo-hua YU ; Gui-mei QU ; Wei-dong YAO ; Lei JIANG
Chinese Journal of Pathology 2010;39(9):631-631
Carcinoma, Medullary
;
pathology
;
Carcinoma, Renal Cell
;
diagnosis
;
metabolism
;
pathology
;
radiotherapy
;
surgery
;
Diagnosis, Differential
;
Humans
;
Keratins
;
metabolism
;
Kidney Neoplasms
;
diagnosis
;
metabolism
;
pathology
;
radiotherapy
;
surgery
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Neoplasms, Squamous Cell
;
pathology
;
Nephrectomy
;
Radiotherapy, Adjuvant
3.Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment.
Lin YANG ; Shi-Ying YU ; Guang-Yuan HU
Chinese Journal of Cancer 2013;32(6):353-356
Pituitary metastasis from renal cell carcinoma is rare and has never been reported for renal cell carcinoma primarily treated with sorafenib. Herein, we present a case of an advanced clear-cell renal cell carcinoma in which pituitary metastasis progressed but extracerebral metastases showed partial response to sorafenib treatment.
Antineoplastic Agents
;
therapeutic use
;
Carcinoma, Renal Cell
;
drug therapy
;
pathology
;
Humans
;
Kidney Neoplasms
;
drug therapy
;
pathology
;
Male
;
Middle Aged
;
Niacinamide
;
analogs & derivatives
;
therapeutic use
;
Phenylurea Compounds
;
therapeutic use
;
Pituitary Neoplasms
;
radiotherapy
;
secondary
;
Radiotherapy, Conformal
4.Renal involment of malignant tumor and its treatment in childhood.
Chinese Journal of Pediatrics 2012;50(11):801-806
Antineoplastic Agents
;
adverse effects
;
Child
;
Child, Preschool
;
Hematopoietic Stem Cell Transplantation
;
adverse effects
;
Humans
;
Kidney Diseases
;
etiology
;
pathology
;
therapy
;
Kidney Neoplasms
;
etiology
;
pathology
;
therapy
;
Neoplasms
;
complications
;
therapy
;
Paraneoplastic Syndromes
;
etiology
;
pathology
;
therapy
;
Radiotherapy
;
adverse effects
;
Risk Factors
;
Tumor Lysis Syndrome
;
etiology
;
pathology
;
therapy
5.A Child with Rapid-onset Respiratory Distress after Chemotherapy, Lung Irriadiation, General Anaesthesia, and Blood Transfusion.
Annals of the Academy of Medicine, Singapore 2015;44(11):548-549
Abdominal Neoplasms
;
complications
;
secondary
;
therapy
;
Acute Lung Injury
;
diagnostic imaging
;
etiology
;
Anemia
;
complications
;
therapy
;
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Child, Preschool
;
Etoposide
;
administration & dosage
;
Fluoroscopy
;
Humans
;
Ifosfamide
;
administration & dosage
;
Kidney Neoplasms
;
pathology
;
Lung Neoplasms
;
complications
;
secondary
;
therapy
;
Male
;
Postoperative Complications
;
diagnostic imaging
;
etiology
;
Prosthesis Implantation
;
Radiography, Thoracic
;
Radiotherapy
;
Respiratory Distress Syndrome, Adult
;
diagnostic imaging
;
etiology
;
Transfusion Reaction
;
Vascular Access Devices